Blog
Q1 2023, Message From The CEO
Transition, taking stock, timing our next run. These have been the themes of the company in Q1 2023. An element of venture company building that has always bothered me and felt misaligned with our founding mission and raison d’etat is the overemphasis on speed. Those in entrepreneurial circles will be familiar with the maxims, “move…
Q4 2022, Message From The CEO
What a year 2022 turned out to be. Our 2nd year in operation had its fair share of challenges and triumphs. And while everything did not go exactly to plan, we ended the year full of excitement for what is to come in 2023. The major highlights of the final quarter of 2022 were: 1.)…
Q3 2022, Message From The CEO
“The reality is, if we want to provide high quality care to all people – because all people deserve high quality care – then we have to bring care to people; we cannot expect people to come to healthcare, to facilities, and to the system. That means we have to move care into the home….
KDE | Chapter One: Cardiovascular Disease
Introduction to Cardiovascular Disease Heart disease accounts for one in every four deaths in the U.S., according to the Centers for Disease Control and Prevention (CDC). Cardiovascular disease (CVD) is a general term for conditions affecting the heart or blood vessels. These conditions develop when plaque builds up in the arteries (atherosclerosis), causing a narrowing…
Q2 2022, Message From The CEO
Where did all the time go? It feels like only 1 week ago that I was writing my first ever “Message from the CEO” for the Q1 Investor Report. I guess it is true what they say: “time flies when you are building a digital health and advocacy startup that is committed to preventing kidney…
